News

Veracyte Announces New Clinical Validation Data for RNA Sequencing-Based Afirma Medullary Thyroid Cancer ... “ MTC is often difficult to distinguish using traditional cytopathology ...
Papillary thyroid cancer is a type of differentiated thyroid cancer, which means it starts in cells that make and release thyroid hormones. It typically forms in only one lobe of the thyroid gland ...
Dr Manisha Shah talks about the importance of genetic testing in medullary thyroid carcinoma and highlights management guidelines for this rare head and neck cancer. X. No Results.
This cancer can occur sporadically or as part of hereditary syndromes, such as multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid cancer (FMTC).
Vierhapper H et al. (2005) Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15: 1267–1272 ...
Veracyte Announces New Data Demonstrating Afirma Xpression Atlas’s Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting ...
There are two types of medullary thyroid cancer: sporadic and familial. Most cases occur in younger people and are sporadic, where the cancer does not run in the family, leaving around 25% of ...
ESTEVE has entered into an agreement with Sanofi to acquire Caprelsa® (vandetanib) rights in more than 50 countries, a treatment that is used in adults and children above 5 years of age to treat ...
Selpercatinib extended PFS compared with two approved multikinase inhibitors for treatment of RET-mutant medullary thyroid cancer, according to the agent’s manufacturer.Selpercatinib (Retevmo ...
Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer. Journal of Nuclear Medicine, 2023; jnumed.123.266537 DOI ...